Clinical Trial Update: Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) [Phase 2]

View source ↗

Summary

A Phase 2 trial update for persistent or permanent non-valvular atrial fibrillation in patients not taking vitamin K antagonists; the study completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Nonvalvular Atrial Fibrillation

Snippet

Sponsor: AstraZeneca | Conditions: Persistent or Permanent Non-valvular Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2011-07-28